(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are INTEXA, ABIVAX, and NEW SOURCES ENERGY.
Financial Asset | Price | Change | Updated (EST) |
---|---|---|---|
INTEXA (ITXT.PA) | 2.92 | 19.67% | 2023-04-07 08:52:39 |
ABIVAX (ABVX.PA) | 9.14 | 13.54% | 2023-04-07 08:36:48 |
NEW SOURCES ENERGY (NSE.AS) | 0.06 | 9.26% | 2023-04-07 08:04:29 |
TELEVERBIER (TVRB.PA) | 45.80 | 9.05% | 2023-04-07 08:05:18 |
IEX GROUP NV (IEX.AS) | 1.80 | 5.88% | 2023-04-07 08:03:40 |
MAUNA KEA TECH (MKEA.PA) | 0.62 | 5.81% | 2023-04-07 08:54:12 |
BELYSSE GROUP (BELYS.BR) | 1.10 | 5.77% | 2023-04-07 08:07:34 |
NEXTENSA (NEXTA.BR) | 43.35 | 5.73% | 2023-04-07 08:16:12 |
BAINS MER MONACO (BAIN.PA) | 95.00 | 5.32% | 2023-04-07 08:45:09 |
ACCOR (AC.PA) | 30.24 | 5.04% | 2023-04-07 08:36:56 |
The three biggest losers today are GENEURO, FERMENTALG, and ITESOFT.
Financial Asset | Price | Change | Updated (EST) |
---|---|---|---|
GENEURO (GNRO.PA) | 2.00 | -9.91% | 2023-04-07 08:51:15 |
FERMENTALG (FALG.PA) | 1.02 | -8.75% | 2023-04-07 08:50:03 |
ITESOFT (ITE.PA) | 3.46 | -7.98% | 2023-04-07 08:52:50 |
MEMSCAP REGPT (MEMS.PA) | 2.75 | -7.41% | 2023-04-07 08:00:23 |
UMG (UMG.AS) | 21.40 | -5.56% | 2023-04-07 08:06:09 |
ERYTECH PHARMA (ERYP.PA) | 0.83 | -5.45% | 2023-04-07 08:48:57 |
RALLYE (RAL.PA) | 1.36 | -5.42% | 2023-04-07 08:02:41 |
FORSEE POWER (FORSE.PA) | 3.32 | -5.14% | 2023-04-07 08:50:53 |
NHOA (NHOA.PA) | 5.10 | -4.85% | 2023-04-07 08:01:06 |
FONCIERE EURIS (EURS.PA) | 3.00 | -3.85% | 2023-04-07 08:50:39 |
Winners today
1. INTEXA (ITXT.PA)
19.67% Price Change
Intexa S.A. engages in the operation of the photovoltaic installation in Saint-André-de-Cubzac, France. The company was founded in 2011 and is headquartered in Saint-Etienne, France. Intexa S.A. is a subsidiary of Casino Guichard-Perrachon.
CAC 40 ended the session with INTEXA jumping 19.67% to €2.92 on Friday while CAC 40 jumped 0.12% to €7,324.75.
Earnings Per Share
As for profitability, INTEXA has a trailing twelve months EPS of €0.1.
PE Ratio
INTEXA has a trailing twelve months price to earnings ratio of 29.2. Meaning, the purchaser of the share is investing €29.2 for every euro of annual earnings.
Volatility
INTEXA’s last week, last month’s, and last quarter’s current intraday variation average was 19.67%, 6.23%, and 18.96%.
INTEXA’s highest amplitude of average volatility was 19.67% (last week), 19.35% (last month), and 18.96% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, INTEXA’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for INTEXA is 15 which is 87.5% above its average volume of 8.
More news about INTEXA.
2. ABIVAX (ABVX.PA)
13.54% Price Change
ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France.
CAC 40 ended the session with ABIVAX rising 13.54% to €9.14 on Friday while CAC 40 jumped 0.12% to €7,324.75.
Earnings Per Share
As for profitability, ABIVAX has a trailing twelve months EPS of €-2.53.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1286.47%.
More news about ABIVAX.
3. NEW SOURCES ENERGY (NSE.AS)
9.26% Price Change
New Sources Energy N.V. develops, operates, exploits, and invests in projects that generates electricity using renewable energy sources. The company was formerly known as Management Share NV and changed its name to New Sources Energy N.V. in July 2011. New Sources Energy N.V. is headquartered in Amersfoort, the Netherlands.
AEX-Index ended the session with NEW SOURCES ENERGY rising 9.26% to €0.06 on Friday, following the last session’s upward trend. AEX-Index rose 0.54% to €759.84, following the last session’s upward trend on what was a somewhat positive trend trading session today.
More news about NEW SOURCES ENERGY.
4. TELEVERBIER (TVRB.PA)
9.05% Price Change
Téléverbier SA engages in the operation of ski lifts in Switzerland. The company is involved in the car parks and locker activities; rental of operating buildings and building surfaces; operation of ski schools; sale and rental of sporting goods; operation of eleven high-altitude restaurants; and sale of catering products, as well as offers catering and accommodation services. It also operates garage workshop and spare parts store for the maintenance of piste groomers; metal construction workshop; and provides maintenance services for ski lift installations. Téléverbier SA was incorporated in 1950 and is headquartered in Verbier, Switzerland.
CAC 40 ended the session with TELEVERBIER jumping 9.05% to €45.80 on Friday, following the last session’s upward trend. CAC 40 rose 0.12% to €7,324.75, following the last session’s upward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, TELEVERBIER has a trailing twelve months EPS of €8.81.
PE Ratio
TELEVERBIER has a trailing twelve months price to earnings ratio of 5.2. Meaning, the purchaser of the share is investing €5.2 for every euro of annual earnings.
Volume
Today’s last reported volume for TELEVERBIER is 98 which is 3.92% below its average volume of 102.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TELEVERBIER’s stock is considered to be oversold (<=20).
More news about TELEVERBIER.
5. IEX GROUP NV (IEX.AS)
5.88% Price Change
IEX Group N.V., through its subsidiaries, operates financial websites in the Netherlands and Belgium. It operates Beurs.nl, Belegger.nl, Beleggen.nl, DeBeurs.nl, Beursonline.nl, Participaties.nl, Beursgorilla.nl, Tostrams.nl and Guruwatch websites. The company also provides investment information services. In addition, the company offers IEX and IEXProfs magazine for various investors; and organizes various events for private individuals and professionals. IEX Group N.V. was founded in 1999 and is based in Amsterdam, the Netherlands.
AEX-Index ended the session with IEX GROUP NV rising 5.88% to €1.80 on Friday while AEX-Index jumped 0.54% to €759.84.
Earnings Per Share
As for profitability, IEX GROUP NV has a trailing twelve months EPS of €0.19.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, IEX GROUP NV’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for IEX GROUP NV is 90 which is 86.54% below its average volume of 669.
More news about IEX GROUP NV.
6. MAUNA KEA TECH (MKEA.PA)
5.81% Price Change
Mauna Kea Technologies SA develops and markets medical devices in Europe and internationally. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.
CAC 40 ended the session with MAUNA KEA TECH jumping 5.81% to €0.62 on Friday, after three successive sessions in a row of gains. CAC 40 rose 0.12% to €7,324.75, following the last session’s upward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, MAUNA KEA TECH has a trailing twelve months EPS of €-0.29.
More news about MAUNA KEA TECH.
7. BELYSSE GROUP (BELYS.BR)
5.77% Price Change
Belysse Group NV produces and sells textile floor coverings in Europe, North America, and internationally. It operates through Residential PA and Commercial segments. The Residential PA segment designs, manufactures, and distributes broadloom carpets and tiles to major retailers and wholesalers under the Balta Broadloom and ITC brands. The Commercial segment designs, manufactures, and distributes modular carpet tiles primarily for offices and public projects under the modulyss, and Bentley brands; and broadloom carpets for the hospitality sector under the arc edition brand to architects, designers, contractors, and distributors. The company was formerly known as Balta Group NV. Belysse Group NV was founded in 1964 and is headquartered in Sint-Baafs-Vijve, Belgium.
BEL 20 ended the session with BELYSSE GROUP rising 5.77% to €1.10 on Friday, following the last session’s upward trend. BEL 20 jumped 0.99% to €3,807.06, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.
More news about BELYSSE GROUP.
8. NEXTENSA (NEXTA.BR)
5.73% Price Change
Nextensa NV/SA is a mixed real estate investor and developer. The company's investment portfolio, which is spread over the Grand Duchy of Luxembourg (46%), Belgium (41%) and Austria (13%), had a total value on 30/09/2022 of approximately €1.35 billion. As a developer, Nextensa is mainly active in shaping large urban developments. At Tour & Taxis (development of more than 350,000 sqm) in Brussels, Nextensa is building a mixed real estate patrimony consisting of the revaluation of iconic buildings and new constructions. In Luxembourg (Cloche d'Or), it is working in partnership on a major urban extension of more than 400,000 sqm consisting of offices, retail and residential units. The company is listed on Euronext Brussels and has a market capitalisation of € 541.1 million (at 30/09/2022).
BEL 20 ended the session with NEXTENSA rising 5.73% to €43.35 on Friday, after two sequential sessions in a row of gains. BEL 20 jumped 0.99% to €3,807.06, after two successive sessions in a row of gains, on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, NEXTENSA has a trailing twelve months EPS of €11.19.
PE Ratio
NEXTENSA has a trailing twelve months price to earnings ratio of 3.87. Meaning, the purchaser of the share is investing €3.87 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.69%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 18, 2023, the estimated forward annual dividend rate is 2.6 and the estimated forward annual dividend yield is 6.52%.
Volume
Today’s last reported volume for NEXTENSA is 9839 which is 34.26% above its average volume of 7328.
More news about NEXTENSA.
9. BAINS MER MONACO (BAIN.PA)
5.32% Price Change
Société Anonyme des Bains de Mer et du Cercle des Étrangers à Monaco operates in the gaming, hotels, and rental sectors in Monaco. The company operates casinos; hotels; restaurants; lounge bars and nightclubs; wellness and leisure facilities; shows and concert halls; shopping centers; and meetings and events centers. It is also involved in the slot machines, table games, and other activities; and rental of shops, offices, shop windows, villas, luxury residential, etc. properties. In addition, the company offers catering services. The company was incorporated in 1863 and is headquartered in Monaco.
CAC 40 ended the session with BAINS MER MONACO rising 5.32% to €95.00 on Friday, following the last session’s upward trend. CAC 40 rose 0.12% to €7,324.75, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, BAINS MER MONACO has a trailing twelve months EPS of €38.73.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 86.62%.
Volume
Today’s last reported volume for BAINS MER MONACO is 1777 which is 173.38% above its average volume of 650.
Yearly Top and Bottom Value
BAINS MER MONACO’s stock is valued at €95.00 at 22:40 EST, below its 52-week high of €99.00 and way above its 52-week low of €63.20.
Volatility
BAINS MER MONACO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.08%, a negative 0.31%, and a positive 1.77%.
BAINS MER MONACO’s highest amplitude of average volatility was 2.74% (last week), 2.44% (last month), and 1.77% (last quarter).
Moving Average
BAINS MER MONACO’s worth is higher than its 50-day moving average of €89.99 and higher than its 200-day moving average of €87.35.
More news about BAINS MER MONACO.
10. ACCOR (AC.PA)
5.04% Price Change
Accor SA operates a chain of hotels worldwide. It operates through two segments, HotelServices, and Hotel Assets & Other. The company owns, operates, manages, and franchises hotels. It also provides digital services to independent hotel operators through D-edge platform; ResDiary, a flat-rate online table reservation system that is designed for restaurant owners; Gekko solutions, including digital hotel distribution and loyalty platforms for the travel industry and large companies; and concierge and customized services through John Paul, as well as hotel booking services; and other services in events, fine dining, and entertainment through Paris Society and Potel & Chabot platforms. In addition, the company offers distribution activities, such as private sales of hotel accommodation and luxury vacations through VeryChic platform; rental of private residences operated by onefinestay; and coworking spaces through Wojo and Mama Works. Further, it provides hotel management, procurement, cash management, IT, and advertising services, as well as various advisory services. The company was founded in 1967 and is headquartered in Issy-les-Moulineaux, France.
CAC 40 ended the session with ACCOR jumping 5.04% to €30.24 on Friday, following the last session’s upward trend. CAC 40 jumped 0.12% to €7,324.75, following the last session’s upward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, ACCOR has a trailing twelve months EPS of €-7.71.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.66%.
Moving Average
ACCOR’s value is above its 50-day moving average of €30.05 and way higher than its 200-day moving average of €26.11.
Yearly Top and Bottom Value
ACCOR’s stock is valued at €30.24 at 22:40 EST, below its 52-week high of €32.49 and way higher than its 52-week low of €20.47.
Volume
Today’s last reported volume for ACCOR is 1050120 which is 25.89% above its average volume of 834114.
More news about ACCOR.
Losers Today
1. GENEURO (GNRO.PA)
-9.91% Price Change
GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody, which has completed Phase IIb clinical trial for multiple sclerosis; and is in Phase IIa to treat type 1 diabetes, as well as is in Phase I for the treatment of chronic inflammatory demyelinating polyneuropathy. It has cooperative research and development agreements with The National Institute of Neurological Disorders and Stroke to develop novel therapeutic antibodies for the treatment of amyotrophic lateral sclerosis; and Academic centers to develop inflammatory psychosis, as well as a research collaboration agreement with International Center for Infectiology Research; and with Northwestern University for human endogenous retrovirus W envelope protein (HERV-W ENV) in long-haul COVID patients. The company was incorporated in 2006 and is headquartered in Plan-les-Ouates, Switzerland.
CAC 40 ended the session with GENEURO sliding 9.91% to €2.00 on Friday, after three successive sessions in a row of losses. CAC 40 rose 0.12% to €7,324.75, following the last session’s upward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, GENEURO has a trailing twelve months EPS of €-0.37.
Volatility
GENEURO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.76%, a negative 2.06%, and a positive 4.37%.
GENEURO’s highest amplitude of average volatility was 3.98% (last week), 4.08% (last month), and 4.37% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GENEURO’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for GENEURO is 6349 which is 18.14% below its average volume of 7756.
More news about GENEURO.
2. FERMENTALG (FALG.PA)
-8.75% Price Change
Fermentalg SA develops, produces, and sells active ingredients extracted from microalgae for the food, health, nutrition, and environment sectors in France and internationally. It offers DHA ORIGINS, a plant-based DHA oil; aquafeeds and pet foods; BLUE ORIGIN, a natural color; and environmental and clean air solutions that captures CO2 in industries. The company was incorporated in 2009 and is headquartered in Libourne, France.
CAC 40 ended the session with FERMENTALG falling 8.75% to €1.02 on Friday while CAC 40 rose 0.12% to €7,324.75.
Earnings Per Share
As for profitability, FERMENTALG has a trailing twelve months EPS of €-0.32.
More news about FERMENTALG.
3. ITESOFT (ITE.PA)
-7.98% Price Change
Itesoft S.A., a software company, provides secure capture and process automation solutions in France and internationally. The company's solutions include ITESOFT Capture as a Service, a solution for capturing information with digitization and the acceleration of exchanges; ITESOFT Capture as a Service for Invoices, provides Cloud-based invoice data extraction, and automation service based on a single and multi-tenant core technology. It also offers ITESOFT Fraud Detection SaaS, a solution that identifies suspicious documents. In addition, the company provides ITESOFT FreeMind, a solution for enterprises to process all document flows in various formats, such as paper, barcode, fax, email, and manuscript; and ITESOFT FreeMind for Invoices, a solution for capturing and extracting supplier invoices. Further, it offers ITESOFT Balance, a solution that handles reconciliation, accounting integration in SAP, and Oracle certified ERP and generic ERP modules; and ITESOFT Analytics that supervises entire process invoices from reception to payments. It serves customers in banking, insurance, commerce, industry, public sector, social organizations, etc. Itesoft S.A. was incorporated in 1984 and is headquartered in Aimargues, France. Itesoft S.A. is a subsidiary of CDML SAS.
CAC 40 ended the session with ITESOFT dropping 7.98% to €3.46 on Friday, after five sequential sessions in a row of losses. CAC 40 rose 0.12% to €7,324.75, following the last session’s upward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, ITESOFT has a trailing twelve months EPS of €-0.1.
Volatility
ITESOFT’s last week, last month’s, and last quarter’s current intraday variation average was a negative 8.67%, a negative 0.20%, and a positive 4.96%.
ITESOFT’s highest amplitude of average volatility was 8.67% (last week), 4.53% (last month), and 4.96% (last quarter).
More news about ITESOFT.
4. MEMSCAP REGPT (MEMS.PA)
-7.41% Price Change
MEMSCAP, S.A. provides micro-electro-mechanical systems (MEMS) based solutions for aerospace and defense, optical communications, medical and biomedical, and IT/consumer markets worldwide. The company offers pressure sensors, pressure transducers, and pressure switches for various applications, such as air data computers, cabin pressure, engine control, altimeters, barometers, cockpit instruments, and air data test sets. It also provides gold coated and titanium-based pressure transducers, plastic domes, line-sets, and related accessories; and magnetic switches/relays, as well as supplies implantable pressure sensors for spinal pressure monitoring, abdominal aortic aneurism, etc. In addition, the company supplies optical MEMS chips for variable optical attenuators in optical telecommunication markets; and provides the multi-user MEMS processes (MUMPs) comprising PolyMUMPs, SOIMUMPs, and PiezoMUMPs, as well as MUMPs-PLUS and post processing services. Further, it offers custom products, including wafers, MEMS dies, and wafer level packaged devices; and manufacturing services, as well as prototyping services. The company sells its products and services to Fortune 500 companies, high-technology industries, research institutes, and universities. MEMSCAP, S.A. was founded in 1997 and is headquartered in Crolles, France.
CAC 40 ended the session with MEMSCAP REGPT dropping 7.41% to €2.75 on Friday, after three successive sessions in a row of losses. CAC 40 jumped 0.12% to €7,324.75, following the last session’s upward trend on what was a somewhat positive trend trading session today.
More news about MEMSCAP REGPT.
5. UMG (UMG.AS)
-5.56% Price Change
Universal Music Group N.V. operates as a music company worldwide. It operates through Recorded Music, Music Publishing, and Merchandising & Other segments. The Recorded Music segment discovers and develops recording artists, as well as markets and promotes their music across various formats and platforms; and engages in the live events, sponsorship, film, and television operations. The Music Publishing segment discovers and develops songwriters, as well as owns and administers the copyright for musical compositions used in recordings, public performances, and related uses, such as films and advertisements. The Merchandising & Other segment produces and sells artist and other branded products through various sales channels, including fashion retail, concert touring, and internet, as well as offers brand rights management services. The company has approximately 3 million recordings, 4 million owned and administered titles, and 220 artists/brands, as well as owns approximately 50 labels covering various music genres. Universal Music Group N.V. was incorporated in 2020 and is headquartered in Hilversum, the Netherlands.
AEX-Index ended the session with UMG falling 5.56% to €21.40 on Friday, after two sequential sessions in a row of losses. AEX-Index jumped 0.54% to €759.84, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, UMG has a trailing twelve months EPS of €0.59.
PE Ratio
UMG has a trailing twelve months price to earnings ratio of 36.27. Meaning, the purchaser of the share is investing €36.27 for every euro of annual earnings.
Volume
Today’s last reported volume for UMG is 2894940 which is 104.35% above its average volume of 1416620.
Volatility
UMG’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.19%, a negative 0.29%, and a positive 1.20%.
UMG’s highest amplitude of average volatility was 2.45% (last week), 1.49% (last month), and 1.20% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, UMG’s stock is considered to be overbought (>=80).
More news about UMG.
6. ERYTECH PHARMA (ERYP.PA)
-5.45% Price Change
ERYTECH Pharma S.A., a biopharmaceutical company, focus on development of red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. It develops eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target the amino acid metabolism of cancer cells and induce tumor starvation. ERYTECH Pharma S.A. was incorporated in 2004 and is headquartered in Lyon, France.
CAC 40 ended the session with ERYTECH PHARMA sliding 5.45% to €0.83 on Friday while CAC 40 jumped 0.12% to €7,324.75.
Earnings Per Share
As for profitability, ERYTECH PHARMA has a trailing twelve months EPS of €-0.01.
Moving Average
ERYTECH PHARMA’s worth is way higher than its 50-day moving average of €0.65 and under its 200-day moving average of €0.85.
More news about ERYTECH PHARMA.
7. RALLYE (RAL.PA)
-5.42% Price Change
Rallye SA, together with its subsidiaries, engages in the food and non-food e-commerce retailing business in France and internationally. The company operates in two segments, Food and General Retailing, and Holdings and Other Activities. It operates hypermarkets, supermarkets, and convenience stores. The company conducts its retailing activities in France primarily under the Casino, Monoprix, and Franprix banners; food retail activities in Latin America mainly under the GPA food banners, Éxito, Disco-Devoto, and Libertad banners; and e-commerce comprising Cdiscount and the Cnova N.V. holding company businesses. It is also involved in the financial investment and management, property development, and energy related activities. The company was founded in 1925 and is headquartered in Paris, France. As of December 31, 2021, Rallye SA operates as a subsidiary of Foncière Euris SA.
CAC 40 ended the session with RALLYE dropping 5.42% to €1.36 on Friday while CAC 40 rose 0.12% to €7,324.75.
Earnings Per Share
As for profitability, RALLYE has a trailing twelve months EPS of €-5.8.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.91%.
Sales Growth
RALLYE’s sales growth for the current quarter is negative 0.3%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, RALLYE’s stock is considered to be overbought (>=80).
More news about RALLYE.
8. FORSEE POWER (FORSE.PA)
-5.14% Price Change
Forsee Power Société anonyme, together with its subsidiaries, engages in the design, manufacture, assemble, and supply of lithium-based battery systems for mobility applications in France, rest of Europe, Asia, the United States, and internationally. It operates in two segments: Heavy Vehicles, and Light Vehicles and Industrial Tech. The company's products are used in the field of autonomy and mobility for applications in bicycles, scooters, rolling stock, medical facilities, home automation, professional tools, etc.; electric transport for applications in buses, trucks, trams, shipping and rail transport, and marine and offshore vessels; and storage of electrical energy for residential, commercial, and industrial market applications. Forsee Power SAS was incorporated in 2007 and is headquartered in Ivry-sur-Seine, France.
CAC 40 ended the session with FORSEE POWER sliding 5.14% to €3.32 on Friday while CAC 40 rose 0.12% to €7,324.75.
Earnings Per Share
As for profitability, FORSEE POWER has a trailing twelve months EPS of €-102.012.
Volume
Today’s last reported volume for FORSEE POWER is 122268 which is 510.21% above its average volume of 20037.
Volatility
FORSEE POWER’s last week, last month’s, and last quarter’s current intraday variation average was 3.30%, 0.56%, and 1.82%.
FORSEE POWER’s highest amplitude of average volatility was 6.01% (last week), 2.33% (last month), and 1.82% (last quarter).
More news about FORSEE POWER.
9. NHOA (NHOA.PA)
-4.85% Price Change
NHOA S.A. provides energy storage and e-mobility solutions. The company offers solar plus storage, utility-scale storage, and industrial microgrids. It also provides charging services and devices for electric and hybrid vehicles. The company offers energy house, power house, and hybrid house; and HyESS, a technology platform for the integration of energy storage system, renewable generation source, as well as conventional generators, as well as Atlante, an eStation that provides fast charging solution. The company was formerly known as ENGIE EPS S.A. and changed its name to NHOA S.A. in July 2021. NHOA S.A. is based in Paris, France. NHOA S.A. is a subsidiary of Taiwan Cement Corporation.
CAC 40 ended the session with NHOA falling 4.85% to €5.10 on Friday, after five successive sessions in a row of losses. CAC 40 rose 0.12% to €7,324.75, following the last session’s upward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, NHOA has a trailing twelve months EPS of €-1.05.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.11%.
Volatility
NHOA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 8.06%, a negative 2.85%, and a positive 2.50%.
NHOA’s highest amplitude of average volatility was 8.06% (last week), 4.56% (last month), and 2.50% (last quarter).
Moving Average
NHOA’s worth is way under its 50-day moving average of €8.12 and way below its 200-day moving average of €9.88.
Volume
Today’s last reported volume for NHOA is 38665 which is 173.11% above its average volume of 14157.
More news about NHOA.
10. FONCIERE EURIS (EURS.PA)
-3.85% Price Change
Foncière Euris SA distributes food and specialized products in France and internationally. The company also owns real estate assets, including shopping centers; and manages commercial real estate properties and private equity portfolio. The company was incorporated in 1970 and is based in Paris, France. Foncière Euris SA operates as a subsidiary of Finatis Société Anonyme.
CAC 40 ended the session with FONCIERE EURIS dropping 3.85% to €3.00 on Friday while CAC 40 rose 0.12% to €7,324.75.
Earnings Per Share
As for profitability, FONCIERE EURIS has a trailing twelve months EPS of €-49.02.
Volatility
FONCIERE EURIS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.85%, a negative 4.65%, and a positive 5.75%.
FONCIERE EURIS’s highest amplitude of average volatility was 6.85% (last week), 4.77% (last month), and 5.75% (last quarter).
More news about FONCIERE EURIS.
Stay up to date with our winners and losers daily report